Sou Hu Cai Jing·2026-02-23 01:14Summary of Key Points Core Viewpoint - Several leading companies across various industries have recently announced share repurchase plans, reflecting their confidence in long-term value and commitment to enhancing shareholder returns [11][22]. Group 1: Share Repurchase Plans - New Point Software completed a share repurchase of 1.8272 million shares, accounting for 0.57% of total shares, with a total expenditure of approximately 49.36 million yuan [1][16]. - Quzhou Dongfeng New Materials Group plans to repurchase shares worth between 50 million to 100 million yuan, with an upper price limit of 6.48 yuan per share, potentially acquiring 7.716 million to 15.432 million shares [3][12]. - Step Long Pharmaceutical completed a repurchase of 6.8564 million shares, representing 0.65% of total shares, with a total payment of approximately 118.5 million yuan [4][14]. - Huatai Medical announced a repurchase plan with a budget of 150 million to 200 million yuan, aiming to buy back 47,620 to 63,490 shares at a maximum price of 315 yuan per share [6][18]. - Hengtong Co., Ltd. plans to repurchase shares worth between 80 million to 100 million yuan, with a maximum price of 14.50 yuan per share, intending to cancel the repurchased shares [6][15]. Group 2: Shareholder Actions - Yinfeng Co. has repurchased 9.43 million shares, accounting for 2.14% of total shares, with a total expenditure of approximately 60.89 million yuan [7][12]. - Spring and Autumn Electronics announced the cancellation of 9.1369 million repurchased shares, reducing total shares from 456 million to 447 million [8][12]. - Yinzuo Co.'s major shareholder completed a share increase of 5.5066 million shares, representing 1.06% of total shares, with an expenditure of approximately 31.63 million yuan [8][12]. - Changshu Bank's executives have increased their holdings by 293,400 shares, with a total expenditure of approximately 2.07 million yuan [9][12]. Group 3: Industry Overview - The companies involved span various sectors, including software services, new materials, pharmaceutical manufacturing, medical devices, logistics, textile printing, consumer electronics, retail, and financial services [11][12]. - New Point Software is a leader in smart procurement, while Step Long Pharmaceutical is a key player in traditional Chinese medicine for cardiovascular diseases [11][18]. - Huatai Medical is recognized as a benchmark for domestic cardiovascular intervention devices, and Hengtong Co. is a core service provider in petrochemical logistics [11][18]. Group 4: Market Context - The share repurchase and increase actions occurred primarily between late January and early February 2026, coinciding with a traditionally sensitive period in the capital market [12][21]. - The actions taken by these companies contrast with the weak performance of the Hong Kong market, particularly in the internet technology sector, highlighting a proactive stance by these firms [22].